IP Library Granted Patent US 7,648,676
Granted Patent B2
US 7,648,676 · App. 10/828,653 · Granted Jan 19, 2010

Process and apparatus for treating implants comprising soft tissue

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,648,676
App. No.
10/828,653
Granted
Jan 19, 2010
Kind
B2
Abstract

The present invention is directed to the field of implants that include soft tissue. More particularly, the present invention is directed to processes for treating implants that include soft tissues such as tendons and ligaments, and to implants produced by such processes. The present invention is also directed to processes and apparatus for improved processing of implants that include soft tissue, by applying kinematic restraint, preferably tension, to the implant or specific portions of the implants during the treatment, and to implants produced by such processes and apparatus. The present techniques yield soft tissue implants having superior structural, mechanical, and/or biochemical integrity.

Claims (59)

1. A process for making an implant more suitable for implantation into a recipient, wherein the implant at least partially comprises a soft tissue, the process comprising:

(a) contacting the implant with a protective agent selected from the group consisting of alcohols and polyols;

(b) contacting the implant with an oxidizing sterilant; and

(c) contacting the implant with a rinsing fluid, further comprising applying tension to the soft tissue at least during part of step (b).

2. The process of claim 1 , wherein at least one of steps (a), (b) or (c) further comprises cyclically increasing and decreasing pressure during the contact with the implant.

3. The process of claim 1 , further comprising:

(d) contacting the implant with an oxidizing sterilant; and

(e) contacting the implant with a rinsing fluid.

4. The process of claim 3 , wherein at least one of steps (a) through (e) further comprises cyclically increasing and decreasing pressure during the contact with the implant.

5. The process of claim 1 , further comprising the step of rinsing the implant with an aqueous solution between steps (b) and (c).

6. The process of claim 1 wherein prior to step (b), the implant contains an amount of the alcohol in the soft tissue sufficient to reduce damage from oxidation to the soft tissue.

7. The process of claim 1 , wherein the rinsing fluid is selected from the group consisting of alcohols, polyols, acetone, water, and mixtures thereof.

8. The process of claim 1 , wherein the rinsing fluid comprises a monohydric alcohol having one to eight carbon atoms.

9. The process of claim 1 , wherein step (b) comprises contacting the implant with an aqueous solution comprising hydrogen peroxide in a concentration range of from about 1% to about 10%.

10. The process of claim 1 , wherein the implant comprises at least one tendon or ligament.

11. The process of claim 1 , wherein the implant comprises a tendon having bone attached thereto.

12. A process for making an implant more suitable for implantation into a recipient, wherein the implant at least partially comprises a soft tissue, the process comprising:

(a) contacting the implant with a protective agent selected from the group consisting of alcohols and polyols;

(b) contacting the implant with an oxidizing sterilant; and

(c) contacting the implant with a rinsing fluid,

further comprising: applying kinematic restraint to the soft tissue during each of steps (a), (b) and (c).

13. The process of claim 12 , wherein at least one of steps (a), (b) or (c) further comprises cyclically increasing and decreasing pressure during the contact with the implant.

14. The process of claim 12 , further comprising:

(d) contacting the implant with an oxidizing sterilant; and

(e) contacting the implant with a rinsing fluid.

15. The process of claim 14 , wherein at least one of steps (a) through (e) further comprises cyclically increasing and decreasing pressure during the contact with the implant.

16. The process of claim 12 , further comprising the step of rinsing the implant with an aqueous solution between steps (b) and (c).

17. The process of claim 12 wherein prior to step (b), the implant contains an amount of the alcohol in the soft tissue sufficient to reduce damage from oxidation to the soft tissue.

18. The process of claim 12 , wherein the rinsing fluid is selected from the group consisting of alcohols, polyols, acetone, water, and mixtures thereof.

19. The process of claim 12 , wherein the rinsing fluid comprises a monohydric alcohol having one to eight carbon atoms.

20. The process of claim 12 , wherein step (b) comprises contacting the implant with an aqueous solution comprising hydrogen peroxide in a concentration range of from about 1% to about 10%.

21. The process of claim 12 , wherein the implant comprises at least one tendon or ligament.

22. The process of claim 12 , wherein the implant comprises a tendon having bone attached thereto.

23. A process for treating an implant so as to sterilize the implant prior to implantation, the implant comprising a soft tissue, the process comprising:

applying tension to the soft tissue while contacting the soft tissue with a cleaning agent.

24. The process of claim 23 wherein from about 0.5 Newton to about 20 Newtons of tension are applied to the soft tissue.

25. The process of claim 23 wherein from about 1 Newton to about 10 Newtons of tension are applied to the soft tissue.

26. The process of claim 23 wherein from about 3 Newtons to about 5 Newtons of tension are applied to the soft tissue.

27. The process of claim 23 wherein the cleaning agent comprises an oxidizing sterilant.

28. The process of claim 27 wherein the oxidizing sterilant is a peroxide.

29. The process of claim 28 , wherein the peroxide is an aqueous solution of hydrogen peroxide.

30. The process of claim 23 wherein the cleaning agent comprises a disinfectant.

31. The process of claim 23 wherein the cleaning agent is a decontaminating agent.

32. The process of claim 23 wherein the cleaning agent comprises a detergent.

33. The process of claim 23 wherein the cleaning agent is selected from the group consisting of alcohols, polyols, detergents, and mixtures and combinations thereof.

34. The process of claim 23 further comprising the step of contacting the implant with an alcohol before contact with the cleaning agent.

35. The process of claim 23 , further comprising the step of contacting the implant with a rinsing fluid after contact with the cleaning agent.

36. The process according to any of claims 23 , 30 , 31 , 32 , or 33 , further comprising the step of cyclically increasing and decreasing pressure while the cleaning agent contacts the implant.

37. The process of claim 23 wherein the implant comprises at least one tendon or ligament.

38. The process of claims 23 wherein the implant comprises a tendon having bone attached thereto.

39. A process for making an implant more suitable for implantation into a recipient, wherein the implant at least partially comprises a soft tissue, the process comprising:

(a) contacting the implant with an alcohol;

(b) contacting the implant with a peroxide for less than about 80 minutes;

(c) contacting the implant with an alcohol; and

(d) applying tension to the implant during at least one of steps (a), (b) or (c).

40. A process for making an implant more suitable for implantation into a recipient, wherein the implant at least partially comprises a soft tissue, the process comprising:

applying tension to the implant;

perfusing the tensioned implant with an alcohol; and

perfusing the tensioned implant with a peroxide for less than about 80 cumulative minutes.

Assignments (12)
SECURITY INTEREST Recorded Sep 25, 2025
From: RTI SURGICAL, INC.; COOK BIOTECH INCORPORATED; TISSX, LLC
To: GOLUB CAPITAL MARKETS LLC, AS COLLATERAL AGENT
Reel/Frame 072924/0721 →
TERMINATION AND RELEASE OF SECURITY INTEREST IN PATENTS AND TRADEMARKS Recorded Sep 25, 2025
From: ARES CAPITAL CORPORATION
To: RTI SURGICAL INC. D/B/A EVERGEN
Reel/Frame 072938/0203 →
RELEASE OF SECURITY INTEREST Recorded Jul 21, 2020
From: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
To: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.
Reel/Frame 053260/0398 →
SECURITY INTEREST Recorded Jul 21, 2020
From: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL (UNITED STATES), INC.
To: ARES CAPITAL CORPORATION, AS SECURITY AGENT
Reel/Frame 053273/0665 →
INTELLECTUAL PROPERTY ASSIGNMENT AGREEMENT Recorded Jul 20, 2020
From: SURGALIGN SPINE TECHNOLOGIES, INC. (FORMERLY KNOWN AS RTI SURGICAL, INC.)
To: RTI OEM, LLC
Reel/Frame 053259/0019 →
CHANGE OF NAME Recorded Jul 20, 2020
From: RTI OEM, LLC
To: RTI SURGICAL, INC.
Reel/Frame 053259/0146 →
CHANGE OF NAME Recorded Jul 20, 2020
From: RTI SURGICAL, INC.
To: SURGALIGN SPINE TECHNOLOGIES, INC.
Reel/Frame 053248/0432 →
RELEASE OF SECURITY INTEREST Recorded Jul 20, 2020
From: ARES CAPITAL CORPORATION, AS AGENT
To: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.; PARADIGM SPINE, LLC; FOURTH DIMENSION SPINE, LLC
Reel/Frame 053257/0652 →
SECURITY INTEREST Recorded Mar 8, 2019
From: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.; PARADIGM SPINE, LLC; FOURTH DIMENSION SPINE, LLC
To: ARES CAPITAL CORPORATION, AS ADMINISTRATIVE AGENT
Reel/Frame 048543/0505 →
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2018
From: TD BANK, N.A., AS ADMINISTRATIVE AGENT
To: RTI SURGICAL, INC.
Reel/Frame 046327/0184 →
RELEASE OF SECURITY INTEREST Recorded Jun 7, 2018
From: TD BANK, N.A., AS ADMINISTRATIVE AGENT
To: RTI SURGICAL, INC.
Reel/Frame 046327/0864 →
SECURITY INTEREST Recorded Jun 6, 2018
From: RTI SURGICAL, INC.; PIONEER SURGICAL TECHNOLOGY, INC.; TUTOGEN MEDICAL, INC.
To: JPMORGAN CHASE BANK, N.A., AS THE ADMINISTRATIVE AGENT
Reel/Frame 046303/0926 →